Acute Pulmonary Embolism
Conditions
Brief summary
Composite of hemodynamic collapse or death from any cause within 30 days after enrollment.
Detailed description
Death from any cause within 30 days after enrollment, Hemodynamic collapse within 30 days after enrollment, Pulmonary embolism-related mortality within 30 days after enrollment, Length of hospital stay, Death from any cause within 90 days after enrollment, Serious adverse events within 30 days after enrollment, Major bleeding within 30 days after enrollment, Recurrent symptomatic venous thromboembolism within 30 days after enrollment
Interventions
DRUGOXYGEN
Sponsors
Fundacion Para La Investigacion Biomedica Del Hospital Universitario Ramon Y Cajal
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Composite of hemodynamic collapse or death from any cause within 30 days after enrollment. | — |
Secondary
| Measure | Time frame |
|---|---|
| Death from any cause within 30 days after enrollment, Hemodynamic collapse within 30 days after enrollment, Pulmonary embolism-related mortality within 30 days after enrollment, Length of hospital stay, Death from any cause within 90 days after enrollment, Serious adverse events within 30 days after enrollment, Major bleeding within 30 days after enrollment, Recurrent symptomatic venous thromboembolism within 30 days after enrollment | — |
Countries
Italy, Spain
Outcome results
None listed